Physician profile
Cynthia Forsthoff
NPI 1841250719
$1,725.26
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,725.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $284.44 | 2019 | |
| Pfizer INC. | $174.58 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $149.56 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $146.47 | 2019 | |
| Merck Sharp & Dohme LLC | $126.83 | 2019 | |
| Amgen INC. | $106.62 | 2019 | |
| Janssen Biotech, INC. | $88.32 | 2019 | |
| Incyte Corporation | $76.75 | 2019 | |
| Exelixis INC. | $73.09 | 2019 | |
| Genentech USA, INC. | $63.31 | 2019 | |
| Celgene Corporation | $62.47 | 2019 | |
| Gilead Sciences, INC. | $45.37 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $39.85 | 2019 | |
| Abbvie INC. | $36.92 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $34.06 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.84 | 2019 | |
| Genzyme Corporation | $30.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.70 | 2019 | |
| Seagen INC. | $24.24 | 2019 | |
| Amag Pharmaceuticals, INC. | $19.04 | 2019 | |
| Tesaro, INC. | $18.44 | 2019 | |
| Emd Serono, INC. | $18.35 | 2019 | |
| Dova Pharmaceuticals | $18.00 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $17.39 | 2019 | |
| Clovis Oncology, INC. | $13.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Forsthoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.